Create a Free Account
or
Create a Free Account
or
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
A recent Beacon Securities report focuses on Curaleaf's strategic financial management and the potential impacts of legisla...
Roth MKM analyst Scott Fortune maintains Trulieve Cannabis (OTC:TCNNF) with a Buy and raises the price target from $16 to $19.
Needham analyst Matt McGinley maintains Trulieve Cannabis (OTC:TCNNF) with a Buy and raises the price target from $13.5 to $...
Trulieve Cannabis Corp. announced on Thursday its first quarter results for the three months ended March 31, 2024. The Tallahas...
As the cannabis industry adapts to its new regulatory environment following the DEA's announcement it would move to
The DEA was expected to move forward with its plans this week to remove cannabis as a Schedule 1 drug, where it currently sits ...
The recent decision by the DEA to reschedule cannabis to Schedule III has triggered notable volatility in the market valuations...
